How a new Israeli health tech fund plans to invest $175M

The latest stories trending on MedCity News.

Editor's Pick

Top Story How Pitango VC Is Planning to Invest Its New $175M Health Tech Fund Pitango Venture Capital, one of the largest venture capital firms in Israel, announced the first closing of a new $175 million healthcare technology fund. With the new fund, the firm plans to build a portfolio of approximately 15 new companies over a period of three to four years. Sponsored Content Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women's Health Presented by AVIA Health and MedCity News Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients - all while using fewer staff resources. If you're building a business case for remote monitoring that seamlessly transitions care from hospital to home, don't miss this opportunity to hear how to effectively navigate the remote monitoring landscape. Sign up today and join the event! We're All Ears If you haven't already, please take 3-5 minutes and tell us what you really think. Your input is valuable and will help us improve MedCity News. As a thank you for your time, you can enter to win a $250 gift card. Tell Us

Featured News

Payer's Place: Don Antonucci, Providence Health Plan The CEO of Providence Health Plan visits the Payer's Place and addresses the future of payment models. Orphan Drug Development Is Next for Tech to Tackle Drug developers need policies and technological infrastructure to execute on their goal of being patient-focused. At a minimum, this means a compliant way to engage patients and truly hear their voices; at its most effective, patient engagement also meets patients where they are – whenever and wherever that may be. Integral Snags $7M In Seed Funding for Its Healthcare Data Privacy Platform Integral raked in $6.9 million in seed funding in this week. The San Francisco-based startup is developing technology that seeks to speed up the process of exchanging sensitive health data while still maintaining robust privacy protection. 3 Ways to Use an Engineering Mindset to Optimize Patient Access Workflows In a day of vast innovation, expansion, and acquisitions, an engineering mindset can bring a unique and effective approach to thinking across the system, evaluating the current and future state, standardizing on best practices, and considering upstream and downstream workflows. Delivering Precision Care to Manage Neurodegenerative Diseases Precision medicine for neurodegenerative conditions has the potential to radically change the way patients are treated and managed over time. As an industry, we must continue to expand our thinking and push the boundaries of science, technology, and data analytics to capture precision medicine opportunities in broader areas of unmet medical needs. A One-Time Treatment for NASH? Kriya Strikes Deal for Liver Disease Gene Therapy Gene therapy biotech Kriya Therapeutics has acquired Tramontane Therapeutics, a startup focused on metabolic diseases. Tramontane brings a gene therapy that's a potential one-time treatment for the fatty liver disease NASH.

Resources

MedCity Pivot Podcast: A Conversation With Unlearn.AI CEO About Clinical Trials The founder and CEO of Unlearn.AI seeks to make clinical trials more efficient and less costly by leveraging its Digital Twin technology. If the company is successful, drugs could potentially be brought to market sooner and in a cost effective manner. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe